NRXS
Neuraxis, Inc.
NYSE MKT: NRXS · HEALTHCARE · BIOTECHNOLOGY
$7.44
-2.23% today
Updated 2026-04-29
Market cap
$93.54M
P/E ratio
—
P/S ratio
26.21x
EPS (TTM)
$-0.95
Dividend yield
—
52W range
$2 – $8
Volume
0.2M
Neuraxis, Inc. (NRXS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | $2.79M | $760482.00 | $1.48M | $509498.00 | $4.76M |
| Cash & equivalents | $1.90M | $320858.00 | $253699.00 | $78560.00 | $3.70M |
| Current assets | $2.46M | $491009.00 | $476957.00 | $242610.00 | $4.27M |
| Total liabilities | $1.15M | $1.59M | $7.05M | $1.91M | $2.69M |
| Current liabilities | $1.01M | $1.42M | $6.98M | $1.89M | $2.43M |
| Long-term debt | — | $51692.00 | — | — | — |
| Shareholder equity | $1.64M | $-825660.00 | $-5.57M | $-1.40M | $2.07M |
| Retained earnings | $-26.12M | $-29.15M | $-33.93M | $-48.56M | $-56.80M |
| Accounts receivable | $311329.00 | $115301.00 | $174399.00 | $73167.00 | $244618.00 |
| Inventory | $106846.00 | $39180.00 | $48133.00 | $21220.00 | $44328.00 |
| Goodwill | — | — | — | — | — |